DEFECTIVE TRANSFER RNA-QUEUINE MODIFICATION IN C3H10T1 2 MURINE FIBROBLASTS TRANSFECTED WITH ONCOGENIC RAS/

Citation
Cj. Morgan et al., DEFECTIVE TRANSFER RNA-QUEUINE MODIFICATION IN C3H10T1 2 MURINE FIBROBLASTS TRANSFECTED WITH ONCOGENIC RAS/, Cancer research, 56(3), 1996, pp. 594-598
Citations number
25
Categorie Soggetti
Oncology
Journal title
ISSN journal
00085472
Volume
56
Issue
3
Year of publication
1996
Pages
594 - 598
Database
ISI
SICI code
0008-5472(1996)56:3<594:DTRMIC>2.0.ZU;2-7
Abstract
tRNA isoacceptors for aspartic acid, asparagine, histidine, and tyrosi ne are modified in the anticodon wobble position with the deazaguanine analogue queuine, Queuine modification is defective in many tumors an d transformed cell lines, and the extent of hypomodification correlate s with staging and outcome in numerous human tumors. The molecular rol e of queuine modification in normal cells and the mechanism of queuine hypomodification in tumors are unknown, We have characterized non-tra nsformed C3H10T1/2 murine fibroblasts (C3H) and their ras-transfected counterparts (RasC4) with respect to the causes and effects of queuine hypomodification, RasC4 cells are hypomodified for queuine compared w ith C3H cells, despite increased tRNA-guanine ribosyltransferase activ ity, Excess exogenous queuine can cause repletion of tRNA queuine leve ls in RasC4 cells. Queuine modification of both C3H and RasC4 cells ca n be decreased by treatment with 7-methylguanine. This treatment does not affect growth in monolayer culture but enhances anchorage-independ ent growth of RasC4 cells greatly. These cell lines may be useful syst ems for the study of queuine function in normal cells and the causes a nd consequences of hypomodification for queuine in tumors.